tbuckley/cabot-search huggingface dataset:
P2.01-82 Neutrophil-to-Lymphocyte Ratio Complements the Prognostic Ability of PD-L1 in Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors
Authors: D. Saravia, S. Agte, N. Okabe, W. Park, D. Kwon, R. Mudad, H. Suzuki, Y. Chae, M. Oh, A. Rahbari, G. Lopes
Journal: Journal of Thoracic Oncology (2018)
PIWI-interacting RNA-54265 is oncogenic and a potential therapeutic target in colorectal adenocarcinoma
Authors: Dongmei Mai, Peirong Ding, Liping Tan, Jialiang Zhang, Zhizhong Pan, Ruihong Bai, Cong Li, Mei Li, Yifeng Zhou, Wen Tan, Zhixiang Zhou, Yexiong Li, Aiping Zhou, Ying Ye, Ling Pan, Yanfen Zheng, Jiachun Su, Zhixiang Zuo, Zexian Liu, Qi Zhao, Xiaoxing Li, Xudong Huang, Wei Li, Siqi Wu, Weihua Jia, Shuangmei Zou, Chen Wu, Rui-Hua Xu, Jian Zheng, Dongxin Lin
Journal: Theranostics (2018)

Although PIWI-interacting RNAs (piRNAs) have recently been linked to human diseases, their roles and functions in malignancies remain unclear. This study aimed to investigate the significance of some piRNAs in colorectal cancer (CRC). Methods: We first analyzed the expression profile of piRNAs in CRC using the TCGA and GEO databases. The top 20 highly expressed piRNAs were selected and tested in our CRC tumor and non-tumor tissue samples. We then examined the relevance of the significantly differentially expressed piRNA to the CRC outcomes in 218 patients receiving postoperative chemotherapy and 317 patients receiving neoadjuvant chemotherapy. A series of biochemical and molecular biological assays were conducted to elucidate the functional mechanism of a piRNA of interest in CRC. Furthermore, experiments with mice xenografts were performed to evaluate the therapeutic effect of an inhibitor specific to the piRNA. Results: We found that among the examined 20 piRNAs, only piRNA-54265 was overexpressed in CRC compared with non-tumor tissues and higher levels in tumor or in serum were significantly associated with poor survival in patients. Functional assays demonstrated that piRNA-54265 binds PIWIL2 protein and this is necessary for the formation of PIWIL2/STAT3/phosphorylated-SRC (p-SRC) complex, which activates STAT3 signaling and promotes proliferation, metastasis and chemoresistance of CRC cells. Treatment with a piRNA-54265 inhibitor significantly suppressed the growth and metastasis of implanted tumors in mice. Conclusion: These results indicate that piRNA-54265 is an oncogenic RNA in CRC and thus might be a therapeutic target.
P2.12-17 Prophylactic Cranial Irradiation Can Not Provide Survival Benefits for Resected Small Cell Lung Cancer Without Lymph Node Involvement
Authors: B. Han, J. Xu, R. Qiao, J. Teng, B. Zhang, S. Wang, J. Qian, Y. Lou, Y. Zhang, X. Zhang, X. Fu, T. Chu, H. Zhong
Journal: Journal of Thoracic Oncology (2018)
Recurrent and metastatic carcinomas of the lacrimal gland: High frequency of ERBB2 driven disease
Authors: N. Girard, R.J. Corona, J. Chung, S.Z. Millis, L.M. Gay, J.A. Elvin, J.-A. Vergilio, S. Ramkissoon, E. Severson, S. Daniel, J.K. Killian, S.M. Ali, A.B. Schrock, V.A. Miller, J.S. Ross
Journal: Annals of Oncology (2018)
Impact of response to preoperative chemotherapy on the outcome of pulmonary metastasectomy for colorectal cancer: Results of a retrospective multicenter study
Authors: T. Okumura, N. Boku, T. Hishida, Y. Ohde, Y. Sakao, K. Yoshiya, M. Higashiyama, K. Kameyama, H. Adachi, K. Shiomi, M. Kanzaki, M. Yoshimura, M. Matsuura, Y. Hata, F. Chen, K. Yoshida, H. Sasaki, I. Hyodo, K. Mori, H. Kondo
Journal: Annals of Oncology (2018)
P1.01-108 Management of Anlotinib-Related Adverse Events: Data From ALTER 0303
Authors: X. Si, L. Zhang, H. Wang, X. Zhang, M. Wang, B. Han, K. Li, Q. Wang, J. Shi, Z. Wang, Y. Cheng, J. He, Y. Shi, W. Chen, X. Wang, Y. Luo, K. Nan, F. Jin, B. Li, Y. Chen, J. Zhou, D. Wang
Journal: Journal of Thoracic Oncology (2018)
Computer-aided prediction of polyp histology on white light colonoscopy using surface pattern analysis
Authors: Cristina Sánchez-Montes, Francisco Sánchez, Jorge Bernal, Henry Córdova, María López-Cerón, Miriam Cuatrecasas, Cristina Rodríguez de Miguel, Ana García-Rodríguez, Rodrigo Garcés-Durán, María Pellisé, Josep Llach, Glòria Fernández-Esparrach
Journal: Endoscopy (2018)

Abstract Background This study aimed to evaluate a new computational histology prediction system based on colorectal polyp textural surface patterns using high definition white light images. Methods Textural elements (textons) were characterized according to their contrast with respect to the surface, shape, and number of bifurcations, assuming that dysplastic polyps are associated with highly contrasted, large tubular patterns with some degree of bifurcation. Computer-aided diagnosis (CAD) was compared with pathological diagnosis and the diagnosis made by endoscopists using Kudo and Narrow-Band Imaging International Colorectal Endoscopic classifications. Results Images of 225 polyps were evaluated (142 dysplastic and 83 nondysplastic). The CAD system correctly classified 205 polyps (91.1 %): 131/142 dysplastic (92.3 %) and 74/83 (89.2 %) nondysplastic. For the subgroup of 100 diminutive polyps (≤ 5 mm), CAD correctly classified 87 polyps (87.0 %): 43/50 (86.0 %) dysplastic and 44/50 (88.0 %) nondysplastic. There were no statistically significant differences in polyp histology prediction between the CAD system and endoscopist assessment. Conclusion A computer vision system based on the characterization of the polyp surface in white light accurately predicted colorectal polyp histology.
Clinical practice evaluation of opioids induced constipation management in oncologic patients: The EIO-50 project
Authors: J. Salvador Bofill, V. Guillem Porta, M. Feyjoo, A. Anton Torres, E. Aranda Aguilar, C. Camps, A. Carrato Mena, M. Constenla Figueiras, J.J. Cruz Hernandez, E. Diaz Rubio, J. Garcia Foncillas, P.N. Gascon, R. Lopez Lopez, B. Soler, Y. Escobar
Journal: Annals of Oncology (2018)
Kinetics of prostate-specific antigen (PSA) as a marker of abiraterone acetate (AA) efficacy in patients (p) with metastatic castrate-resistant prostate cancer (mCRPC)
Authors: S. España Fernandez, J.M. Piulats, N. Sala, J.M. Velarde, U. Ferrandiz, O. Etxaniz Ulazia, L. Heras Lopez, M.P. Barretina Ginesta, X. Garcia del Muro, A. Font
Journal: Annals of Oncology (2018)
P2.09-01 Tumor-Associated Immune Cell Infiltration Patterns in Early Stage Squamous Lung Carcinoma
Authors: H. Yu, D. Merrick, M. Tsao, W. Richards, L. Chirieac, M. Watson, C. Rivard, D. Harpole, R. Bueno, A. Bokhoven, F. Hirsch, W. Franklin
Journal: Journal of Thoracic Oncology (2018)
Incorporation of a Molecular Prognostic Classifier Improves Conventional Non–Small Cell Lung Cancer Staging
Authors: Johannes R. Kratz, Greg J. Haro, Nancy R. Cook, Jianxing He, Stephen K. Van Den Eeden, Gavitt A. Woodard, Matthew A. Gubens, Thierry M. Jahan, Kirk D. Jones, Il-Jin Kim, Biao He, David M. Jablons, Michael J. Mann
Journal: Journal of Thoracic Oncology (2019)
The need of re-biopsy: Increase in PD-L1 expression from initial stage to recurrence of non-small cell lung cancer
Authors: M. Lacour, S.Y. Lee, U. Rulle, A. Soltermann, E.J. Rushing, D. Soldini, S. Hiltbrunner, W. Weder, A. Curioni-Fontecedro
Journal: Annals of Oncology (2018)
A first-in-human phase I study of GC1118, a novel monoclonal antibody inhibiting epidermal growth factor receptor (EGFR), in patients with colorectal cancer and gastric/GEJ cancer
Authors: D.-Y. Oh, K.-W. Lee, S.-W. Han, J.W. Kim, J.-W. Shin, S.-J. Jo, N.H. Kim, A. Woo, J. Won, S. Hahn, H. Lee, W.H. Kim, Y.-J. Bang
Journal: Annals of Oncology (2018)
Awareness and attitude towards breast cancer among Egyptian nurses at university affiliated hospitals: Tanta University Hospitals experience
Authors: M.A. Alm El-Din, S.E. Amer, M.A. Elsayed, A.M. Elgohary, A. Ismael, A. Zakzouk, K.M. Emara, F. Elkady, S. Elnahrawy, F. Nada, A. Eissa
Journal: Annals of Oncology (2018)
A first-in-class, first-in-human phase I/IIa trial of CAN04, targeting interleukin-1 receptor accessory protein (IL1RAP), in patients with solid tumors
Authors: A. Awada, F.A.L.M. Eskens, D.G. Robbrecht, U.N. Lassen, M. Sorensen, J.H.M. Schellens, J.S. de Groot, C. Jungels, P.G. Aftimos, S.O. Fretland, L. Thorsson, T.K. Guren
Journal: Annals of Oncology (2018)
A phase Ib study of navicixizumab &amp; weekly paclitaxel in heavily pre-treated platinum resistant ovarian, primary peritoneal or fallopian tube cancer
Authors: S. Fu, B. Corr, E. Hamilton, R.A. Burger, R. Wenham, R.W. Naumann, R. Stagg, K.N. Moore
Journal: Annals of Oncology (2018)
P1.01-10 Stage III Non-Small Cell Lung Cancer Clinical Outcomes with Surgical Resection After Definitive Neoadjuvant Chemoradiotherapy
Authors: I. Caturegli, M. Vyfhuis, W. Burrows, M. Suntharalingam, S. Badiyan, K. Scilla, S. Carr, J. Friedberg, G. Henry, S. Stewart, C. Simone Ii, P. Mohindra
Journal: Journal of Thoracic Oncology (2018)
MA24.01 Genomic Evolution Trajectory Depicts Invasiveness Acquisition from Pre-invasive to Invasive Adenocarcinoma
Authors: C. Zhang, Z. Xie, F. Xu, J. Su, S. Dong, Q. Nie, Y.W. Shao, Q. Zhou, J.-. Yang, X. Yang, X. Zhang, Y. Wu, W. Zhong
Journal: Journal of Thoracic Oncology (2018)
P3.03-27 Somatic BRCA1/2 Mutations in Advanced NSCLC Patients: Description of a Sub-Population from the Ongoing Unicancer SAFIR02-Lung / IFCT-1301 Trial
Authors: J. Remon, E. Rouleau, F. Barlesi, A. Leary, I. Bièche, B. Job, L. Lacroix, A. Auguste, M. Mauduit, C. Audigier-Valette, J. Raimbourg, A. Madroszyk, S. Michiels, M.A. Bayar, M. Jimenez, J. Soria, B. Besse
Journal: Journal of Thoracic Oncology (2018)
KEYNOTE-022 Part 3: Phase II randomized study of 1L dabrafenib (D) and trametinib (T) plus pembrolizumab (Pembro) or placebo (PBO) for BRAF-mutant advanced melanoma
Authors: P.A. Ascierto, P.F. Ferrucci, R. Stephens, M. Del Vecchio, V. Atkinson, H. Schmidt, J. Schachter, P. Queirolo, G.V. Long, A.M. Di Giacomo, I. Svane, M. Lotem, G. Bar-Sela, F. Couture, B.P. Mookerjee, R. Ghori, N. Ibrahim, B. Homet Moreno, A. Ribas
Journal: Annals of Oncology (2018)
P2.17-17 Multimodal Treatment in Pathologically Confirmed Single-Station Resectable IIIA-N2 Non-Small Cell Lung Cancer: A Single Center Experience
Authors: L. Tilea, E. Acosta, M. Majem, I. Sullivan, A. Barba Joaquín, E. Martínez, J.c. Trujillo, J. Belda, G. Gómez De Segura, J. Craven-Bartle, A. Giménez, V. Camacho, A. Fernández, A. Torrego, V. Pajares, L. López, N. Farré
Journal: Journal of Thoracic Oncology (2018)
Randomized, double-blind, placebo (P)-controlled phase III non-inferiority study of darbepoetin alfa (D) for anemia in patients (pts) with advanced NSCLC: An ad hoc subgroup analysis of pts with baseline hemoglobin (Hb) ≤10.0 g/dL
Authors: D. Henry, V. Hirsh, K. Kubota, T. Steinmetz, G. Thomas, J.-H. Kang, D. Gordon, S. Orlov, A.N. Fleishman, C. De Oliveira Brandao
Journal: Annals of Oncology (2018)
MA20.10 Lung Cancer Prediction Using Deep Learning Software: Validation on Independent Multi-Centre Data
Authors: H. Peschl, D. Han, P. Van Ooijen, M. Oudkerk, M. Dorrius, M. Rook, R. Vliegenthart, C.P. Heussel, N. Batora, H. Kauczor, C. Da Silva, O. Von Stackelberg, R. Rubtsov, M. Wielputz, S. Ather, M. Tsakok, C. Arteta, L. Pickup, S. Hussain, W. Hickes, P. Novotny, C. Santos, E. Fay, J. Declerck, V. Potesil, T. Kadir, F. Gleeson
Journal: Journal of Thoracic Oncology (2018)
P3.03-01 BRAF V600 and Non-V600 Mutations in Chinese Lung Cancer
Authors: Y. Gao, R. Chang, J. Huan, X. Xiao, Y. Liu, Y. Zhou, L. Li, Y. Cheng, C. Zhang, P. Dai, Y. Guan, X. Yi, X. Xia, L. Yang
Journal: Journal of Thoracic Oncology (2018)
Almost 2500 GP practices and hospitals are in areas with dangerous air pollution levels
Authors: Adrian O’Dowd
Journal: BMJ (2018)

More than a third of GP practices and a quarter of hospitals in England are situated in areas that exceed safe levels of air pollution, it has been revealed, endangering the health of clinicians and patients.

Research carried out the British Lung Foundation into almost 10 000 health centres across England, Scotland, and Wales showed that more than 2000 centres were in geographical areas with levels of fine particulate matter (PM2.5) above the World Health Organisation’s recommended safe limits.

For its report,1 the charity gathered postcodes for hospitals and GP surgeries from the NHS digital database, including data on 9989 health centres—1457 hospitals and 8532 GP practices. …
Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV)
Authors: A. Mersiades, A. Tognela, P.S. Haber, M. Stockler, N. Lintzeris, J. Simes, I. McGregor, I. Olver, D.J. Allsop, C. Gedye, A. Kirby, R.L. Morton, K. Briscoe, P. Fox, M. Aghmesheh, N. Wong, A. Bhardwaj, A.D. Tran, C. Hahn, P. Grimison
Journal: Annals of Oncology (2018)
Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial
Authors: M.V. Dieci, P.F. Conte, G. Bisagni, A.A. Brandes, A. Frassoldati, L. Cavanna, A. Musolino, F. Giotta, A. Rimanti, O. Garrone, E. Bertone, K. Cagossi, S. Sarti, A. Ferro, C. Omarini, A. Maiorana, E. Orvieto, M. Sanders, R. D'Amico, V. Guarneri
Journal: Annals of Oncology (2018)
P3.01-42 Phase II Trial Allowed Surgery After Induction Chemotherapy of CBDCA+PTX, Bevacizumab in Patients with Stages IIIA-IV Nonsquamous NSCLC
Authors: K. Imai, T. Nakagawa, I. Matsuzaki, K. Orino, H. Saito, K. Sato, M. Sano, Y. Sato, S. Motoyama, H. Shibata, Y. Minamiya
Journal: Journal of Thoracic Oncology (2018)
A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results
Authors: M. Lacouture, H. Dion, S. Ravipaty, V.R. Akmaev, R. Sarangarajan, J.J. Jimenez, N.R. Narain, B. Berman, S. Goldfarb
Journal: Annals of Oncology (2018)
Prognostic impact of anthracyclines and immune/proliferation markers in TNBC according to pCR after de-escalated neoadjuvant chemotherapy with 12 weeks of nab-paclitaxel/carboplatin or gemcitabine: Survival results of WSG-ADAPT-TN phase II trial
Authors: O. Gluz, U. Nitz, C. Liedtke, M. Christgen, E.-M. Grischke, H. Forstbauer, M. Braun, M. Warm, J. Hackmann, C. Uleer, B. Aktas, C. Schumacher, C. Lindner, S. Kümmel, R.E. Kates, J. Potenberg, P. Staib, R. Wuerstlein, H.H. Kreipe, N. Harbeck
Journal: Annals of Oncology (2018)
P2.04-12 A Genomic Signature [JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2] Predicts Baseline Resistance to Nivolumab in Advanced NSCLC.
Authors: S. Pilotto, G. Grizzi, I. Sperduti, M. Simbolo, C. Vicentini, A. Caliò, M. Caccese, A. Mafficini, L. Carbognin, V. Corbo, A. Gkountakos, A. Santo, M. Infante, M. Brunelli, A. Scarpa, G. Tortora, E. Bria
Journal: Journal of Thoracic Oncology (2018)
Multicentre, double-blind, randomised phase II study evaluating gemcitabine with or without ramucirumab as II line treatment for MPM
Authors: M. Pagano, F. Zanelli, R. Gnoni, C. Bonelli, M. Tiseo, L. Boni, G.L. Ceresoli, P.A. Zucali, F. Grosso, G. Pasello, F. Cappuzzo, C. Pinto
Journal: Annals of Oncology (2018)
Endotypes of chronic rhinitis: A cluster analysis study
Authors: Yifan Meng, Hongfei Lou, Yang Wang, Xiaoyan Wang, Feifei Cao, Kuiji Wang, Xiaohan Chu, Chengshuo Wang, Luo Zhang
Journal: Allergy (2018)

Abstract Background Chronic rhinitis ( CR ) is currently regarded as a syndrome, which presents as several endotypes. The aim of this study was to identify the CR endotype clusters and investigate the inflammatory patterns associated with the different endotypes. Methods A total of 259 CR patients and 20 control subjects were enrolled in this prospective study. Twelve clinical variables were analyzed using cluster analysis and five inflammatory variables were measured to investigate the inflammatory patterns associated with the different clusters. Results Six endotype clusters of CR were defined in the Chinese CR patients. Patients in cluster 1 (38.6%) were diagnosed as allergic rhinitis ( AR ) without asthma, and in cluster 2 (13.5%) as AR with asthma, with all demonstrating positive results for local eosinophils and high levels of local and serum IgE. Similarly, patients in cluster 3 (18.6%) were diagnosed as nonallergic rhinitis with eosinophilia syndrome ( NARES ) without asthma and in cluster 5 (5.0%) as NARES with asthma, with all demonstrating positive results for local eosinophils, and negative results for both local and serum IgE. Patients in cluster 4 (4.6%) were diagnosed as local allergic rhinitis and showed positive results for local eosinophils and local IgE, but negative results for serum IgE, whereas patients in cluster 6 (19.7%) were diagnosed as idiopathic rhinitis because of high symptoms scores, but negative findings for local eosinophils, local IgE, and serum IgE. Conclusions Chinese CR patients may be clustered into six endotypes with different inflammatory patterns, which may help in delivering individualized treatment.
Association of LIPI score with immune checkpoint inhibitors (ICI) outcomes in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients (pts)
Authors: R.G. Herrera Gomez, L. Mezquita, E. Auclin, K. Saleh, N. Baste Rotllan, M. Iacobs, S.C. Bursuc, L. Mayache Badis, F.R. Ferrand, O. Casiraghi, S. Temam, I. Breuskin, Y. Tao, B. Besse, C. Even
Journal: Annals of Oncology (2018)
OA01.05 Phase II Study of Neo-Adjuvant Chemo/Immunotherapy for Resectable Stages IIIA Non-Small Cell Lung Cancer- Nadim Study-SLCG
Authors: M. Provencio, E. Nadal, A. Insa, R. García Campelo, G. Huidobro, M. Domine, M. Majem, D. Rodríguez-Abreu, V. Calvo, A. Martinez-Marti, J. De Castro, M. Cobo Dols, G. Lopez-Vivanco, E. Del Barco, R. Bernabé, N. Vinolas, I. Barneto, B. Massuti
Journal: Journal of Thoracic Oncology (2018)
Repeated Vaccination May Protect Children From Influenza Infection
Authors: Sarah Cobey
Journal: JAMA Network Open (2018)

Huong Q. McLean, PhD, MPH; Herve Caspard, MD, ScD; Marie R. Griffin, MD, MPH; Manjusha Gaglani, MD; Timothy R. Peters, MD; Katherine A. Poehling, MD, MPH; Christopher S. Ambrose, MD, MBA; Edward A. Belongia, MD
Abstract 12359: Clinical Impact of Left Ventricular Trabeculae in Hypertrophic Cardiomyopathy: Insights From Cardiac Magnetic Resonance Analysis
Authors: Masakazu Yasuda, Yoshitaka Iwanaga, Takayuki Kawamura, Yuki Miyaji, Takashi Nakamura, Shunichi Miyazaki
Journal: Circulation (2015)

Introduction: Hypertrabeculation has been associated with adverse events in patients with left ventricular (LV) non-compaction. However, the clinical significance remains unclear in patients with other cardiomyopathies. Hypothesis: LV trabeculae analyzed by cardiac magnetic resonance (CMR) may have a pathophysiological significance and clinical impact in patients with HCM. Methods: 102 HCM patients receiving regular outpatient treatment underwent CMR. LV volume and mass were analyzed from short-axis cine images using a steady-state free precession sequence and LV fibrosis mass were obtained from late gadolinium enhancement imaging. Individual trabeculae and papillary muscles (TPM) and papillary muscles (PM) were manually planimetered separately on each end-diastolic frame in every slice. Trabeculae (T) was calculated by subtraction of PM from TPM. The data were compared with those of 22 normal control subjects (Cont). Results: In total HCM patients, LV mass index (compacted muscle excluding TPM) was 83.5 ± 23.6 g/m2. TPM mass index were greater in patients with HCM compared with Cont (21.7 ± 7.3 vs 12.4 ± 2.5 g/m2, p &lt; 0.001), and T mass index were also greater (16.8 ± 6.6 vs 9.2 ± 2.2 g/m2, p &lt;0.001). Greater TPM and T masses were associated with more substantial LV mass (r = 0.662 and 0.572, both p &lt;0.001). By multivariate analysis, increased T mass index was independently associated with LV outflow-tract obstruction, increased LV end-diastolic volume index, and LV fibrosis mass index. Kaplan-Meier analysis showed that baseline TPM or T mass index was not associated with cardiovascular outcomes during 14.7 months follow-up. However, baseline T mass / LV mass ratio was significantly associated with the clinical outcomes (p = 0.0124). Conclusions: Alterations of LV trabeculae in HCM may be associated with LV hemodynamic stress and LV remodeling. Furthermore, trabeculae mass to LV compacted mass ratio may be a useful marker for the prognosis in patients with HCM.
Health-related quality of life (HRQoL) in patients with early-stage pancreatic cancer (ESPC) receiving adjuvant or neoadjuvant chemotherapy (A/NAC): A systematic literature review (SLR)
Authors: T. Macarulla Mercade, A. Hendifar, C.-P. Li, M. Reni, H. Riess, M.A. Tempero, A. Dueck, M.F. Botteman, C. Deshpande, E. Lucas, D.-Y. Oh
Journal: Annals of Oncology (2018)
A phase Ib and randomised phase II trial of pazopanib with or without fosbretabulin in advanced recurrent ovarian cancer
Authors: R.D. Morgan, G.C. Jayson, S. Banerjee, A.R. Clamp, A.R. Lyon, W.D. Ryder, R. Hutson, N. Mescallado, C. Orbegoso Aguilar, S. Taylor, J. Tugwood, M. Hall, C. Dive, G.J.S. Rustin
Journal: Annals of Oncology (2018)
P1.13-13 Potent Anti-Tumor Effect of Ganetespib in Acquired EGFR-TKI Resistance NSCLC Cells
Authors: E. Kurihara, K. Shien, H. Torigoe, Y. Takahashi, Y. Ogoshi, T. Yoshioka, K. Namba, H. Sato, H. Yamamoto, J. Soh, S. Toyooka
Journal: Journal of Thoracic Oncology (2018)
P2.17-30 Serum Lipoprotein(A) Correlates with the Effect of Endostar Combined with Concurrent Chemoradiotherapy in Patients with Locally Advanced LSCC
Authors: H. Yang, M. Wang, B. Wang, X. Wu, W. Wang, C. Zhou, D. Lv, F. Kong
Journal: Journal of Thoracic Oncology (2018)
The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction
Authors: Reinhard Schneppenheim, Natalie Hellermann, Maria A. Brehm, Ulrike Klemm, Tobias Obser, Volker Huck, Stefan W. Schneider, Cécile V. Denis, Alexander Tischer, Matthew Auton, Winfried März, Emma-Ruoqi Xu, Matthias Wilmanns, Rainer B. Zotz
Journal: Blood (2018)
Changes of <scp>NGF</scp> pathway in allergic rhinoconjunctivitis: A conjunctival allergen challenge study
Authors: Marta Sacchetti, Marco Segatto, Alice Bruscolini, Irene Abicca, Carlo Cavaliere, Alessandro Lambiase
Journal: Allergy (2018)

Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.